Wonderful efficacy results with Breast Cancer mentioned in the press release today AND physicians might use a blood test to learn which of the 70% of patients may respond to the drug. Then consider the amazing safety profile for this drug that is already known.
This news is beautiful.
(11)
(0)
CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.